Cross-platform analytical assessment of serum GFAP quantification in multiple sclerosis: SIMOA versus two automated immunoassays.

In a complementary mixed-effects model, ΔLumipulse emerged as a significant predictor of ΔSIMOA ( β = 0.51, SE = 0.16, p = 0.002), whereas ΔAlinity showed only a trend toward significance ( β = 0.31, SE = 0.15, p = 0.051).

also in 3,729 other papers